Biblio

Export 41 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is I  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
L. Iaccarino, Chiotis, K., Alongi, P., Almkvist, O., Wall, A., Cerami, C., Bettinardi, V., Gianolli, L., Nordberg, A., and Perani, D., “A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.”, J Alzheimers Dis, vol. 59, no. 2, pp. 603-614, 2017.
L. Iaccarino, Marelli, S., Iannaccone, S., Magnani, G., Ferini-Strambi, L., and Perani, D., “Severe Brain Metabolic Decreases Associated with REM Sleep Behavior Disorder in Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 52, no. 3, pp. 989-97, 2016.
R. Iban-Arias, Trageser, K. J., Yang, E. - J., Griggs, E., Radu, A., Naughton, S., Rahim, M. Al, Tatsunori, O., Raval, U., Palmieri, J., Huang, Z., Chen, L. - C., and Pasinetti, G. Maria, “Exposure to World Trade Center Dust Exacerbates Cognitive Impairment and Evokes a Central and Peripheral Pro-Inflammatory Transcriptional Profile in an Animal Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 2, pp. 779-794, 2023.
M. Ibarria, Alegret, M., Valero, S., Morera, A., Guitart, M., Cañabate, P., Moreno, M., Lara, S., Diego, S., Hernández, J., Tantinyá, N., Vera, M., Hernandez, I., Becker, J. T., Ruiz, A., Boada, M., and Tárraga, L., “Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 559-66, 2016.
N. Faeizah Ibrahim, Yanagisawa, D., Durani, L. Wati, Hamezah, H. Shahirah, Damanhuri, H. Ahmad, Ngah, W. Zurinah Wa, Tsuji, M., Kiuchi, Y., Ono, K., and Tooyama, I., “Tocotrienol-Rich Fraction Modulates Amyloid Pathology and Improves Cognitive Function in AβPP/PS1 Mice.”, J Alzheimers Dis, vol. 55, no. 2, pp. 597-612, 2017.
A. - V. Idland, Wyller, T. Bruun, Støen, R., Eri, L. Magne, Frihagen, F., Ræder, J., Chaudhry, F. Abbas, Hansson, O., Zetterberg, H., Blennow, K., Bogdanovic, N., Brækhus, A., and Watne, L. Otto, “Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium.”, J Alzheimers Dis, vol. 55, no. 1, pp. 371-379, 2017.
E. Idrizbegovic, Hederstierna, C., and Rosenhall, U., “Mismatch Negativity and Ear Laterality in Alzheimer's Disease and in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1405-10, 2016.
M. Ienca, Fabrice, J., Elger, B., Caon, M., Pappagallo, A. Scoccia, Kressig, R. W., and Wangmo, T., “Intelligent Assistive Technology for Alzheimer's Disease and Other Dementias: A Systematic Review.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1301-1340, 2017.
M. Igase, Ohara, M., Igase, K., Kato, T., Okada, Y., Ochi, M., Tabara, Y., Kohara, K., and Ohyagi, Y., “Skin Autofluorescence Examination as a Diagnostic Tool for Mild Cognitive Impairment in Healthy People.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1481-1487, 2017.
E. T. Ighodaro, Nelson, P. T., Kukull, W. A., Schmitt, F. A., Abner, E. L., Caban-Holt, A., Bardach, S. H., Hord, D. C., Glover, C. M., Jicha, G. A., Van Eldik, L. J., Byrd, A. X., and Fernander, A., “Challenges and Considerations Related to Studying Dementia in Blacks/African Americans.”, J Alzheimers Dis, vol. 60, no. 1, pp. 1-10, 2017.
M. Ihara and Saito, S., “Drug Repositioning for Alzheimer's Disease: Finding Hidden Clues in Old Drugs.”, J Alzheimers Dis, vol. 74, no. 4, pp. 1013-1028, 2020.
M. Ihara and Washida, K., “Linking Atrial Fibrillation with Alzheimer's Disease: Epidemiological, Pathological, and Mechanistic Evidence.”, J Alzheimers Dis, vol. 62, no. 1, pp. 61-72, 2018.
S. Ikeda, Mimura, M., Ikeda, M., Wada-Isoe, K., Azuma, M., Inoue, S., and Tomita, K., “Economic Burden of Alzheimer's Disease Dementia in Japan.”, J Alzheimers Dis, vol. 81, no. 1, pp. 309-319, 2021.
J. J. Iliff, Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., G Vates, E., Deane, R., Goldman, S. A., Nagelhus, E. A., and Nedergaard, M., “A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β.”, Sci Transl Med, vol. 4, no. 147, p. 147ra111, 2012.
A. Imai, Matsuoka, T., and Narumoto, J., “Emotional Dysregulation in Mild Behavioral Impairment Is Associated with Reduced Cortical Thickness in the Right Supramarginal Gyrus.”, J Alzheimers Dis, vol. 93, no. 2, pp. 521-532, 2023.
B. Imtiaz, Tolppanen, A. Maija, Solomon, A., Soininen, H., and Kivipelto, M., “Estradiol and Cognition in the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) Cohort Study.”, J Alzheimers Dis, vol. 56, no. 2, pp. 453-458, 2017.
K. K. Indorewalla, O'Connor, M. K., Budson, A. E., DiTerlizzi, C. Guess, and Jackson, J., “Modifiable Barriers for Recruitment and Retention of Older Adults Participants from Underrepresented Minorities in Alzheimer's Disease Research.”, J Alzheimers Dis, vol. 80, no. 3, pp. 927-940, 2021.
A. P. Ingber, Hassenstab, J., Fagan, A. M., Benzinger, T. L. S., Grant, E. A., Holtzman, D. M., Morris, J. C., and Roe, C. M., “Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1055-64, 2016.
K. E. Innes, Selfe, T. Kit, Brundage, K., Montgomery, C., Wen, S., Kandati, S., Bowles, H., Khalsa, D. Singh, and Huysmans, Z., “Effects of Meditation and Music-Listening on Blood Biomarkers of Cellular Aging and Alzheimer's Disease in Adults with Subjective Cognitive Decline: An Exploratory Randomized Clinical Trial.”, J Alzheimers Dis, vol. 66, no. 3, pp. 947-970, 2018.
K. E. Innes, Selfe, T. Kit, Khalsa, D. Singh, and Kandati, S., “Meditation and Music Improve Memory and Cognitive Function in Adults with Subjective Cognitive Decline: A Pilot Randomized Controlled Trial.”, J Alzheimers Dis, vol. 56, no. 3, pp. 899-916, 2017.
K. E. Innes, Selfe, T. Kit, Khalsa, D. Singh, and Kandati, S., “Effects of Meditation versus Music Listening on Perceived Stress, Mood, Sleep, and Quality of Life in Adults with Early Memory Loss: A Pilot Randomized Controlled Trial.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1277-98, 2016.
Y. Inui, Ito, K., and Kato, T., “Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.”, J Alzheimers Dis, vol. 60, no. 3, pp. 877-887, 2017.
K. Iqbal, Liu, F., Gong, C. - X., and Grundke-Iqbal, I., “Tau in Alzheimer disease and related tauopathies.”, Curr Alzheimer Res, vol. 7, no. 8, pp. 656-64, 2010.
F. Oluwasegun Ishabiyi, Ogidi, J. Okwudirich, Olukade, B. Adejoke, Amorha, C. Christabel, El-Sharkawy, L. Y., Okolo, C. Calistus, Adeniyi, T. Mary, Atasie, N. Hope, Ibrahim, A., and Balogun, T. Adewale, “Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S67-S85, 2023.
A. Ishikawa, Tokunaga, M., Maeda, J., Minamihisamatsu, T., Shimojo, M., Takuwa, H., Ono, M., Ni, R., Hirano, S., Kuwabara, S., Ji, B., Zhang, M. - R., Aoki, I., Suhara, T., Higuchi, M., and Sahara, N., “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1037-1052, 2018.

Pages